Comparison of antimicrobial effects of dexmedetomidine and etomidate-lipuro with those of propofol and midazolam

European Journal of Anaesthesiology

Volumn 23, Issue 12, 2006, Pages 1037-1040

  Keleş, Gönül Tezcan ^a,b,c   Kurutepe, S ^a   Tok, D ^a   Gazi, H ^a   Dinc G ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^c Erzene Mahallesi   (Turkey)

Author keywords

Adrenergic alpha agonists, dexmedetomidine; Agents antimicrobial; Anaesthetics intravenous, etomidate, midazolam, propofol; Antimicrobial activity

Indexed keywords

AGAR; ANTIINFECTIVE AGENT; DEXMEDETOMIDINE; ETOMIDATE; MIDAZOLAM; PROPOFOL;

ACINETOBACTER BAUMANNII; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM COLONY; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; IN VITRO STUDY; INOCULATION; INTENSIVE CARE PSYCHOSIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ACINETOBACTER BAUMANNII; ADRENERGIC ALPHA-AGONISTS; ANESTHETICS, INTRAVENOUS; ANTI-INFECTIVE AGENTS; DEXMEDETOMIDINE; DRUG EVALUATION, PRECLINICAL; EQUIPMENT CONTAMINATION; ESCHERICHIA COLI; ETOMIDATE; HUMANS; MIDAZOLAM; PROPOFOL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TEMPERATURE; TIME FACTORS;

EID: 33750374559     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506000949     Document Type: Article

References (16)

1. Berry CB, Gillespie T, Hood J, Scott NB. Growth of micro organisms in solutions of intravenous anaesthetic agents. Anaesthesia 1993; 48: 30-32.
2. Sosis MB, Braverman B. Growth of Staphylococcus aureus in four intravenous anesthetics. Anesth Analg 1993; 77: 766-768.
3. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59: 263-268.
4. Doenicke AW, Roizen MF, Hoernecke R, Lorenz W, Ostwald P. Solvent for etomidate may cause pain and adverse effects. Br J Anaesth 1999; 83: 464-466.
5. Arduino MJ, Bland LA, McAllister SK et al. Microbial growth and endotoxin production in the intravenous anaesthetic propofol. Infect Control Hosp Epidemiol 1991; 12: 535-539.
6. Tessler M, Dascal A, Gioseffini S, Miller M, Mendelson J. Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media. Can J Anaesth 1992; 39: 509-511.
7. Farrington M, McGinnes J, Matthews I, Park GR. Do infusions of midazolam and propofol pose an infection risk to critically ill patients? Br J Anaesth 1994; 72: 415-417.
8. Graystone S, Wells MF, Farrell DJ. Do intensive care drug infusions support microbial growth? Anaesth Intens Care 1997; 25: 640-642.
9. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard 6th edn. National Committee for Clinical Laboratory Standards 2003; M7-A6, Wayne, Pennsylvania, USA.
10. Sakuragi T, Yanagisawa K, Shirai Y, Dan K. Growth of Escherichia coli in propofol, lidocaine, and mixtures of propofol and lidocaine. Acta Anaesthesiol Scand 1999; 43: 476-479.
11. Thomas DV. Propofol supports bacterial growth. Br J Anaesth 1991; 66: 274.
12. Harvey BR, Ganzberg S. Growth of micro organisms in propofol and methohexital mixtures. J Oral Maxillofac Surg 2003; 61: 818-823.
13. Magee L, Godsiff L, Matthews I, Farrington M, Park GR. Anaesthetic drugs and bacterial contamination. Eur J Anaesthesiol Suppl 1995; 12: 41-43.
14. Crowther J, Hrazdil J, Jolly DT, Galbraith JC, Greacen M, Grace M. Growth of micro organisms in propofol, thiopental, and a 1:1 mixture of propofol and thiopental. Anesth Analg 1996; 82: 475-478.
15. Gudmundsson A, Erlendsdottir H, Gottfredsson M, Gudmundsson S. Impact of pH and cationic supplementation on in vitro postantibiotic effect. Antimicrob Agent Chemother 1991; 35: 2617-2624.
16. Langevin PB, Gravenstein N, Doyle TJ et al. Growth of Staphylococcus aureus in diprivan and intralipid: implications on the pathogenesis of infections. Anesthesiology 1999; 91: 1394-1400.